Necrotising fasciitis

Necrotising fasciitis is an infection of the subcutaneous tissue/fat and fascia of the skin. It spreads rapidly along the fascial plane. Muscles are less commonly affected/ affected later in the disease due to better blood supply.

This image shows the different parts of the skin and subcutaneous tissue and which skin/soft tissue infection affects which part of the tissue.

Classification

Type 1 – polymicrobial/synergistic

  • Aerobic and anaerobic bacteria (Often derived from gut/bowel)

Type 2 – monomicrobial

  • Group A Streptococcus (Strep pyogenes), occasionally Staph aureus (especially in neonates).

Type 3

  • Vibrio spp mainly;

  • Other organism – Pasteurella multocida, Haemophilus influenzae , Klebsiella spp. and Aeromonas spp.

  • Common in Asia, associated with seafood/seawater.

Type 4

  • Fungal

  • Candida in immunocompromised or zygomycetes in immunocompetent patients.

  • Type 1 is the commonest (up to 80% of cases).

  • Type 4 has the highest mortality.

  • Some authorities classify the necrotising fasciitis as only of two types –
    Type 1 – polymicrobial.
    Type 2 – monomicrobial (NF caused by Vibrio, fungus etc., falls into this category).

Mortality

Approx 20%. It is a surgical emergency

What are the common sites for necrotising fasciitis

  • Perineum and lower extremities (commonest)

  • Surgical site,

  • Upper extremities,

  • abdomen,

  • Mouth

  • Face

What are the predisposing factors

  • Trauma – including surgery

  • Burns

  • Skin and soft tissue infection

  • Immunosuppression

  • Obesity/malnutrition

  • Alcoholism

  • Peripheral vascular disease

  • Intravenous drug abuse and

  • Diabetes mellitus - the most common preexisting medical condition

  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

  • Recent varicella-zoster - especially in children.

Presentation

  • Common sign/symptoms are – swelling (75%), pain (72.9%), and erythema (66.3%) [Diab, BMJ 2020].

  • The skin changes often do not reflect the extent of the damage.

  • Pain could be out of proportion to skin changes.

  • Anaesthesia over the infected area also could be present.

  • One-fifth of patients have influenza-like symptoms characterised by fever and myalgia

  • Inflammatory markers (WCC, CRP) could be raised along with creatine kinase and creatinine.

  • Patients may deteriorate rapidly, developing signs of sepsis. In the later stage NF could present with visible bruising, bullae and cutaneous necrosis

Management

It is a surgical emergency – an immediate surgical referral must be done.
Inform the intensive care about potential post-operative care and organ support.

  • Debridement.

  • Haemodynamic support.

  • Broad-spectrum empirical antibiotic.

Infection control and public health:

  • Isolation of the patient until group A Streptococcus is excluded as a pathogen

  • If group A Streptococcus isolated - the patient should be isolated as per local policy for invasive group A Streptococcus infection.

  • If group A Streptococcus is isolated – inform public health.

Antibiotics should cover both type 1 and type 2 pathogens.

  1. A broad-spectrum antibiotic with Gram-negative and Gram-positive cover – Pip-tazobactam or a carbapenem (e.g. meropenem).

  2. An antibiotic to inhibit group A Streptococcus toxin production – Clindamycin or Linezolid.

  3. An antibiotic to cover MRSA (according to the local microbiology or presence of risk factors for MRSA) – Vancomycin or daptomycin or linezolid.